AtaGenix Laboratories
Contact us
EN
CN
Antibody Discovery
Rapid Single B Rabbit
Rapid Hybridoma
Phage Display
Naïve Library Panning
Immune Library Construction & Panning
pAb Multi-species
Anti-small molecules
Anti-PTM
Anti-ldiotype
Neutralizing/Blocking
Protein Services test
HEK293 Expression System HEK293
Baculovirus Expression System
E. coli Expression System
Bacillus subtilis System
Yeast Expression System
MHC I Complex Preparation
+86-27-87001869
Home
Protein Services
Mammalian
CHO Transient
HEK293 Transient
Stable Cell Line
E. Coli
Bacillus
Yeast
Insect
MHC I preparation
Scale ups
Antibody Discovery
By Method
Rapid Single B Rabbit
Rapid Hybridoma
Phage Display
Naïve Library Panning
Immune Library Construction & Panning
pAb Multi-species
By Application
Anti-small molecules
Anti-PTM
Anti-ldiotype
Neutralizing/Blocking
Antibody Engineering
Humanization & Sequence Optimization
Affinity Maturation
SPR
Featured Products
Enzymatic Tools
Featured Kits
RapidStain™
RTiterFast™AquaAdjuvant
Support Center
Resource Downloads
Case Studies
ExpressPro Protein
AbPro™ Antibody
Enginuity™ Antibodies
Research Publishing
Media Hub
FAQs
Publication Insights
Protein Services test
HEK293 Expression System HEK293
Baculovirus Expression System
E. coli Expression System
Bacillus subtilis System
Yeast Expression System
MHC I Complex Preparation
About us
Company Profile
Contact us
News
Rapid Mouse Monoclonal Antibody Development
Rapid Rabbit Polyclonal Antibody Development
Phage Display Nanobody Development
Single B Rabbit Monoclonal Antibodies
Rapid Mouse Monoclonal Antibody Development
Rapid Rabbit Polyclonal Antibody Development
Phage Display Nanobody Development
Single B Rabbit Monoclonal Antibodies
Home
-
Support Center
-
FAQs
FAQs
Types and Biological Significance of Post-Translational Modifications (PTMs)?
AtaGenix offers diverse protein purification methods, including affinity chromatography, size-exclusion chromatography (SEC), ion exchange chromatography,
Support Center
Resource Downloads
Case Studies
Research Publishing
Media Hub
FAQs
Publication Insights
Messages
* Country
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North Korea
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
